← Back to Search

Transcranial Magnetic Stimulation

Treatment Arm for Depression, Bipolar Disorder

N/A

Waitlist Available

Led By Peter Zandi, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, at post treatment up to 5 days

Awards & highlights

Study Summary

This trial will study a new type of brain stimulation to see if it's safe and effective for treating mental health issues.

Eligible Conditions

Depression, Bipolar Disorder
Bipolar Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, at post treatment up to 5 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, at post treatment up to 5 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, at post treatment up to 5 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Montgomery-Asberg Depression Rating Scale (MADRS) score

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment ArmExperimental Treatment1 Intervention

Open label study, all participants will receive novel iTBS

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT®(Stanford Accelerated Intelligent Neuromodulation Therapy)

2023

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Baszucki Brain Research FundOTHER

6 Previous Clinical Trials

305 Total Patients Enrolled

Magnus MedicalIndustry Sponsor

1 Previous Clinical Trials

1,000 Total Patients Enrolled

University of Texas at AustinOTHER

350 Previous Clinical Trials

80,974 Total Patients Enrolled

Media Library

Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT® (Transcranial Magnetic Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05375214 — N/A

Depression, Bipolar Disorder Research Study Groups: Treatment Arm

Depression, Bipolar Disorder Clinical Trial 2023: Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT® Highlights & Side Effects. Trial Name: NCT05375214 — N/A

Magnus Transcranial Magnetic Neuromodulation System (MNS) with SAINT® (Transcranial Magnetic Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05375214 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research require further participants to enroll?

"As per clinicaltrials.gov, this medicinal study is actively seeking out participants for enrollment. The trial was initially posted on March 3rd 2023 and its most recent update happened on the 29th of the same month."

Answered by AI

Are individuals aged 20 or older eligible for this research venture?

"This clinical trial has an upper age limit of 65 and a lower qualifying age of 22, in keeping with the eligibility criteria."

Answered by AI

What is the planned sample size of this clinical trial?

"Affirmative. According to clinicaltrials.gov, this research has been posted since March 3rd 2023 and was last updated on the 29th of that month. 10 volunteers are being recruited from two different healthcare centres for participation in the trial."

Answered by AI

Are there any restrictions for individuals wanting to join this clinical trial?

"In order to be eligible for participation, prospective patients must suffer from either depression or bipolar disorder and fall between the ages of 22 and 65 years old. This clinical trial is currently aiming to accrue 10 individuals in total."

Answered by AI